Sign inJoin waitlistJoin the waitlist

Anna Andrzejczyk

Medical Oncologist · Stony Brook Medicine

Credentials: · · · · ·

History

Stony Brook Medicine
Present

Hematology and Medical Oncology
Stony Brook Medicine
2021–2024
Stony Brook Medicine
2018–2021
Renaissance School of Medicine at Stony Brook University
2014–2018

Research

Differential transcriptional regulation of meis1 by Gfi1b and its co-factors LSD1 and CoREST
PLoS ONE · 2013 · 26 citations
Detection of rare mutations in the dystrophin gene
Medycyna wieku rozwojowego · 2009 · 1 citations
Biologics and Drug-Induced Immunogenicity: A Case Report of Acquired Hemophilia A Presenting After Immunotherapy
Case report · Clinical Case Reports · 2026 · Last of 5 authors · Corresponding

Ananya SenGupta
1 paper
Jules Cohen
1 paper
Kevin Murgas
1 paper · 1 as a resident
Luke Li
1 paper
Michael Schuster
1 paper
Qingping Yao
1 paper
Samuel Soff
1 paper · 1 as a resident
SC
Sashank Cherukuri
1 paper · 1 as a fellow
SP
Stephen Poos
1 paper · 1 as a resident
SN
Sundus Nasim
1 paper · 1 as a resident
Tahmeena Ahmed
1 paper
Vincent DeStefano
1 paper · 1 as a resident

Clinical trials

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032